ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Geriatric Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

8,174Medicare Part D Prescriptions Filled, Including Refills

Rank: 39 out of 107

$584K Total Retail Price of All Prescriptions

Rank: 25 out of 107

411 Patients Receiving at Least One Drug in Part D
81%Patients 65 Years and Older
36% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Pennsylvania
Lower avg

Schedule Two
Controlled Substances

11% of this provider’s 411 patients filled at least one prescription for a schedule two drug, compared to an average of 14%.

Schedule Three
Controlled Substances

12% of this provider’s 411 patients filled at least one prescription for a schedule three drug, compared to an average of 6%.

Risky Drugs to Seniors

1% of this provider’s 6,765 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

24% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$71 was the average price of a prescription from this provider, compared to $50 among peers.

Prescriptions per Patient

20 is the average number of prescriptions (including refills) per patient, compared to an average of 29.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Pennsylvania
ATORVASTATIN CALCIUM 356 311 1 17
LEVOTHYROXINE SODIUM 353 293 2 1
AMLODIPINE BESYLATE 281 244 3 5
WARFARIN SODIUM 261 238 4 8
OMEPRAZOLE 252 220 5 6
FUROSEMIDE 184 168 6 3
METOPROLOL SUCCINATE 161 149 7 15
SIMVASTATIN 155 126 8 2
METOPROLOL TARTRATE 146 119 9 7
LISINOPRIL 136 118 10 4
ISOSORBIDE MONONITRATE ER 118 92 11 30
PRAVASTATIN SODIUM 116 82 12 32
HYDROCODONE-ACETAMINOPHEN 115 104 S3 13 20
GABAPENTIN 108 62 14 11
HYDROCHLOROTHIAZIDE 105 99 15 14
FLUTICASONE PROPIONATE 91 89 16 54
AZITHROMYCIN 89 67 17 87
SERTRALINE HCL 88 59 18 12
METFORMIN HCL 88 70 18 13
LOSARTAN POTASSIUM 87 74 20 36
PANTOPRAZOLE SODIUM 77 67 21 28
LANSOPRAZOLE 71 67 22 189
GLIMEPIRIDE 69 52 23 84
POTASSIUM CHLORIDE 67 53 24 18
KLOR-CON M10 66 58 25 97
NEXIUM 65 58 26 61
FLUOXETINE HCL 64 47 27 102
BUMETANIDE 63 60 28 77
JANTOVEN 60 60 29 62
CARVEDILOL 59 52 30 25
CYCLOBENZAPRINE HCL 58 27 R 31 128
PAROXETINE HCL 57 36 32 80
SYNTHROID 57 55 32 85
ZETIA 54 41 34 126
DIOVAN 54 52 34 33
LIPITOR 54 42 34 132
CYMBALTA 53 13 37 52
CLOPIDOGREL 53 51 37 29
PREDNISONE 52 41 39 39
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 18, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.